
  
    
      
        
        Dementia_NNP remains_VBZ an_DT incurable_JJ condition_NN and_CC its_PRP$ increasing_VBG prevalence_NN is_VBZ a_DT deeply_RB
        worrying_VBG aspect_NN of_IN the_DT “ graying_NN” of_IN the_DT population_NN ._. An_DT important_JJ question_NN for_IN researchers_NNS
        is_VBZ to_TO establish_VB whether_IN dementia_NN incidence_NN ,_, prevalence_NN ,_, and_CC national_JJ history_NN vary_VBP from_IN one_CD
        location_NN to_TO another_DT ._. Incidence_NNP studies_NNS are_VBP particularly_RB valuable_JJ for_IN less_RBR biased_VBN comparison_NN
        of_IN disease_NN occurrence_NN ,_, as_RB well_RB as_IN being_VBG essential_JJ for_IN policy_NN makers_NNS ._. Many_JJ biases_NNS can_MD ,_,
        however_RB ,_, be_VB introduced_VBN in_IN such_JJ studies_NNS ._. Dropout_NNP and_CC mortality_NN are_VBP particular_JJ reasons_NNS for_IN
        concern_NN ._.
        Most_JJS of_IN the_DT numerous_JJ studies_NNS of_IN dementia_NN incidence_NN have_VBP been_VBN restricted_VBN to_TO single_JJ sites_NNS ._.
        Authors_NNP have_VBP frequently_RB attempted_VBN to_TO assess_VB whether_IN rates_NNS in_IN a_DT given_VBN study_NN are_VBP similar_JJ to_TO
        those_DT obtained_VBN elsewhere_RB ._. However_RB ,_, variations_NNS between_IN studies_NNS in_IN the_DT methodology_NN employed_VBN
        make_VB such_JJ comparisons_NNS unreliable_JJ ._. Where_WRB within-country_JJ variations_NNS in_IN incidence_NN have_VBP been_VBN
        noted_VBN ,_, as_IN has_VBZ happened_VBN in_IN the_DT US_NNP ,_, they_PRP have_VBP often_RB been_VBN ascribed_VBN to_TO methodological_JJ
        differences_NNS ,_, but_CC one_CD cannot_NN be_VB certain_JJ whether_IN this_DT is_VBZ the_DT case_NN ._.
        Risk_NN factors_NNS for_IN other_JJ chronic_JJ disorders_NNS common_JJ in_IN old_JJ age_NN (_( notably_RB cardiovascular_JJ
        disease_NN and_CC cancers_NNS )_) do_VBP vary_VBP in_IN their_PRP$ prevalence_NN between_IN and_CC within_IN countries_NNS ._. In_IN the_DT UK_NNP ,_,
        for_IN example_NN ,_, the_DT incidence_NN of_IN stroke_NN is_VBZ known_VBN to_TO vary_VB considerably_RB across_IN the_DT country_NN ._. A_DT
        high_JJ proportion_NN of_IN dementia_NN patients_NNS are_VBP thought_VBN to_TO have_VB a_DT vascular_NN component_NN to_TO their_PRP$
        dementia_NN ,_, and_CC it_PRP has_VBZ been_VBN assumed_VBN that_DT dementia_NN incidence_NN could_MD be_VB reduced_VBN if_IN vascular_NN risk_NN
        were_VBD better_RBR controlled_JJ ._. One_CD way_NN to_TO test_VB this_DT hypothesis_NNS is_VBZ to_TO compare_VB sites_NNS with_IN known_VBN
        variation_NN in_IN vascular_NN risk_NN to_TO assess_VB whether_IN there_EX is_VBZ also_RB variation_NN in_IN the_DT incidence_NN of_IN
        dementia_NN ._.
        The_DT Medical_NNP Research_NNP Council_NNP Cognitive_NNP Function_NNP and_CC Ageing_NNP Study_NNP (_( MRC_NNP CFAS_NNP )_) is_VBZ a_DT
        multi-site_JJ ,_, population-based_JJ study_NN in_IN the_DT UK_NNP of_IN individuals_NNS aged_VBN 65_CD years_NNS and_CC over_IN living_VBG
        in_IN the_DT community_NN ,_, including_VBG institutions_NNS ._. Diverse_NNP sites_NNS have_VBP been_VBN chosen_VBN ,_, with_IN varying_VBG
        exposures_NNS of_IN potential_JJ importance_NN in_IN dementia_NN ._. A_DT two-phase_JJ two-wave_JJ design_NN has_VBZ been_VBN
        employed_VBN ,_, with_IN the_DT waves_NNS two_CD years_NNS apart_RB ._. A_DT standard_JJ set_NN of_IN instruments_NNS for_IN the_DT diagnosis_NN
        of_IN dementia_NN is_VBZ used_VBN throughout_IN ._. CFAS_NNP now_RB publishes_VBZ incidence_NN estimates_NNS from_IN five_CD sites_NNS ,_,
        using_VBG likelihood-based_JJ methods_NNS to_TO compare_VB the_DT first_JJ two_CD waves_NNS of_IN interviews_NNS ._.
        Predictably_RB ,_, incidence_NN rates_NNS of_IN dementia_NN ,_, for_IN both_DT sexes_NNS ,_, were_VBD found_VBN to_TO rise_VB with_IN age_NN ,_,
        from_IN 6_CD ._. 7_CD per_IN 1_CD ,_, 000_CD person_NN years_NNS at_IN age_NN 65_CD –_NN 69_CD years_NNS to_TO 68_CD ._. 5_LS per_IN 1_CD ,_, 000_CD person_NN years_NNS at_IN age_NN 85_CD
        years_NNS and_CC above_IN ._. The_DT authors_NNS estimate_VBP that_IN around_IN 163_CD ,_, 000_CD new_JJ cases_NNS of_IN dementia_NN occur_VB in_IN
        England_NNP and_CC Wales_NNP each_DT year_NN ._. However_RB ,_, there_EX was_VBD no_DT convincing_JJ evidence_NN of_IN variation_NN across_IN
        sites_NNS ,_, and_CC the_DT incidence_NN rates_NNS do_VBP not_RB reflect_VB the_DT variations_NNS in_IN the_DT prevalence_NN of_IN possible_JJ
        risk_NN factors_NNS in_IN these_DT sites_NNS ._. We_PRP therefore_RB cannot_NN assume_VB that_DT action_NN to_TO reduce_VB vascular_NN risk_NN
        will_MD have_VB a_DT significant_JJ impact_NN on_IN dementia_NN incidence_NN ._.
        Another_DT issue_NN addressed_VBN by_IN the_DT study_NN is_VBZ previous_JJ suggestions_NNS in_IN the_DT literature_NN that_DT
        dementia_NN incidence_NN rates_NNS might_MD be_VB lower_JJR in_IN the_DT oldest_JJS age_NN groups_NNS ._. The_DT limited_JJ number_NN of_IN
        respondents_NNS in_IN these_DT age_NN groups_NNS in_IN previous_JJ studies_NNS made_VBD it_PRP impossible_JJ to_TO test_VB this_DT
        hypothesis_NNS ._. The_DT CFAS_NNP ,_, however_RB ,_, found_VBD no_DT evidence_NN of_IN any_DT such_JJ tailing_VBG off_IN in_IN incidence_NN ,_,
        which_WDT also_RB has_VBZ implications_NNS for_IN policy_NN and_CC planning_NN ._.
        The_DT CFAS_NNP is_VBZ important_JJ because_IN it_PRP provides_VBZ the_DT first_JJ multi-site_JJ comparison_NN of_IN incidence_NN
        rates_NNS in_IN ethnically_RB homogeneous_JJ populations_NNS within_IN a_DT country_NN ,_, and_CC within_IN Europe_NNP ,_, using_VBG
        identical_JJ methodology_NN across_IN sites_NNS ._. The_DT methodological_JJ approach_NN developed_VBN for_IN the_DT study_NN
        will_MD also_RB be_VB of_IN value_NN for_IN researchers_NNS undertaking_VBG other_JJ studies_NNS of_IN dementia_NN incidence_NN ,_, and_CC
        in_IN other_JJ chronic_JJ disease_NN studies_NNS involving_VBG a_DT two-phase_JJ selection_NN process_NN ._.
      
    
  
